about
Solution structure of the major factor VIII binding region on von Willebrand factorThe defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragmentPlasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand FactorsIsolation, subunit structure, and proteolytic modification of bovine factor VIII.Molecular structural studies of human factor VIII.Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasmaMonoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombinPurified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.Generation of factor VIII coagulant activity by isolated, perfused neonatal pig livers and adult rat livers.Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.Liver transplantation in pigs with von Willebrand's disease.Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.Epilogue--hemophilia in 1974: theory and practice.The effect of clotting on structure and function of human factor VIII.Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
P2860
Q27682916-39563B96-E04B-4B8D-B01C-B316F13F3F54Q34469121-CD18ACDB-746A-4F09-9319-48CAB0036B09Q34482160-73C10B36-39F6-414A-AE19-F0BAEDE40932Q34737319-7496D315-BC97-4529-86E8-25C817655439Q34889382-88129236-7628-4BA2-821D-E37CFC1ABCBBQ34889432-C981D383-149D-4CAA-804C-D44E7CA9B2C1Q35199709-60D05318-8F19-4254-9050-831DA700F6D1Q35467075-0488612E-9B1F-4BE2-8FA1-5EF904CD6FAEQ36275218-71C5156A-1FB5-4519-9AEC-24D610F22AD5Q37031904-F252CD0A-F318-4BE3-BFE0-C0185FF3BADBQ37046074-897AFD3B-3255-4484-B79F-BB50D49F9547Q37047369-7F137D18-4429-4AB1-B08C-83FEAD3EE732Q37559120-8FBBE3FB-3855-4650-B0F0-869BFEDBEDD4Q37582676-A898E9C2-E5E9-4A60-8D79-95F3CFEB09DDQ40728130-1EEF77DE-657F-45F7-A118-A759915D7CF7Q41676536-B687B679-746B-4392-B0AD-1EC59A23C5ECQ43594721-75D87467-D4C4-4FB3-B89D-2AC83BEB320CQ44108483-BA3F1A8B-64D7-4185-88BE-C658338C0FABQ45863872-9CF70F13-672A-4B4C-B647-5B2D30444E8CQ45878078-1D319568-3454-4513-977A-B75BB16B83D7Q45878175-C64B8B7C-E3FA-407C-ADF9-D991579961F1Q47325711-13B25CB4-DF7C-43E0-9875-CF00E74F24FB
P2860
description
1973 nî lūn-bûn
@nan
1973 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Factor VIII recombination after dissociation by CaCl12.
@ast
Factor VIII recombination after dissociation by CaCl12.
@en
type
label
Factor VIII recombination after dissociation by CaCl12.
@ast
Factor VIII recombination after dissociation by CaCl12.
@en
prefLabel
Factor VIII recombination after dissociation by CaCl12.
@ast
Factor VIII recombination after dissociation by CaCl12.
@en
P2093
P2860
P356
P1476
Factor VIII recombination after dissociation by CaCl12.
@en
P2093
P2860
P304
P356
10.1073/PNAS.70.8.2326
P407
P577
1973-08-01T00:00:00Z